BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 34874962)

  • 1. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up.
    Tleyjeh IM; Saddik B; AlSwaidan N; AlAnazi A; Ramakrishnan RK; Alhazmi D; Aloufi A; AlSumait F; Berbari E; Halwani R
    PLoS One; 2021; 16(12):e0260568. PubMed ID: 34874962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hospitalized patients with COVID-19: A cohort study with 4 months median follow-up.
    Tleyjeh IM; Saddik B; Ramakrishnan RK; AlSwaidan N; AlAnazi A; Alhazmi D; Aloufi A; AlSumait F; Berbari EF; Halwani R
    J Infect Public Health; 2022 Jan; 15(1):21-28. PubMed ID: 34861604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
    Lancet; 2021 Jan; 397(10270):220-232. PubMed ID: 33428867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.
    Elias TP; Gebreamlak TW; Gebremeskel TT; Adde BL; Abie AS; Elias BP; Argaw AM; Tenaw AA; Belay BM
    PLoS One; 2024; 19(5):e0298409. PubMed ID: 38728331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long COVID outcomes following omicron wave in non-hospital population.
    Ruiyin W; Qi J; Tingting W; Yuqin Y; Yan J; Kun P
    Front Public Health; 2024; 12():1377866. PubMed ID: 38560433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
    Ghosn J; Bachelet D; Livrozet M; Cervantes-Gonzalez M; Poissy J; Goehringer F; Gandonniere CS; Maillet M; Bani-Sadr F; Martin-Blondel G; Tattevin P; Launay O; Surgers L; Dudoignon E; Liegeon G; Zucman D; Joseph C; Senneville E; Yelnik C; Roger PM; Faure K; Gousseff M; Cabié A; Duval X; Chirouze C; Laouénan C;
    Clin Microbiol Infect; 2023 Feb; 29(2):254.e7-254.e13. PubMed ID: 36191847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study.
    Søraas A; Kalleberg KT; Dahl JA; Søraas CL; Myklebust TÅ; Axelsen E; Lind A; Bævre-Jensen R; Jørgensen SB; Istre MS; Kjetland EF; Ursin G
    PLoS One; 2021; 16(8):e0256142. PubMed ID: 34437579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-Discharge Symptoms among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study.
    Ogoina D; James HI; Ogoinja SZ
    Am J Trop Med Hyg; 2021 Jul; 105(3):731-736. PubMed ID: 34270448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: Post-recovery long-term symptoms among patients in Saudi Arabia.
    Khodeir MM; Shabana HA; Rasheed Z; Alkhamiss AS; Khodeir M; Alkhowailed MS; Alharbi S; Alsoghair M; Alsagaby SA; Al Abdulmonem W
    PLoS One; 2021; 16(12):e0260259. PubMed ID: 34879074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post COVID-19 sequelae: A prospective observational study from Northern India.
    Naik S; Haldar SN; Soneja M; Mundadan NG; Garg P; Mittal A; Desai D; Trilangi PK; Chakraborty S; Begam NN; Bhattacharya B; Maher G; Mahishi N; Rajanna C; Kumar SS; Arunan B; Kirtana J; Gupta A; Patidar D; Kodan P; Sethi P; Ray A; Jorwal P; Kumar A; Nischal N; Sinha S; Biswas A; Wig N
    Drug Discov Ther; 2021 Nov; 15(5):254-260. PubMed ID: 34719599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post‑COVID‑19 Syndrome in Outpatients: a Cohort Study.
    Desgranges F; Tadini E; Munting A; Regina J; Filippidis P; Viala B; Karachalias E; Suttels V; Haefliger D; Kampouri E; Van Singer M; Tschopp J; Rochat Stettler L; Schaad S; Brahier T; Hugli O; Mueller Y; Gouveia A; Opota O; Carron PN; Guery B; Papadimitriou-Olivgeris M; Boillat-Blanco N;
    J Gen Intern Med; 2022 Jun; 37(8):1943-1952. PubMed ID: 35319081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and Health Outcomes Among Survivors of COVID-19 Infection 1 Year After Discharge From Hospitals in Wuhan, China.
    Zhang X; Wang F; Shen Y; Zhang X; Cen Y; Wang B; Zhao S; Zhou Y; Hu B; Wang M; Liu Y; Miao H; Jones P; Ma X; He Y; Cao G; Cheng L; Li L
    JAMA Netw Open; 2021 Sep; 4(9):e2127403. PubMed ID: 34586367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews.
    Karaarslan F; Demircioğlu Güneri F; Kardeş S
    Rheumatol Int; 2021 Jul; 41(7):1263-1271. PubMed ID: 33978818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-COVID syndrome: A prospective study in a tertiary hospital of Nepal.
    Shah S; Bhattarai SR; Basnet K; Adhikari YR; Adhikari TB; Bhatta N; Chamlagain R; Aryal S; Sah SK; Bhandari G; Bhandari B; Poudel S; Pant P; Das SK
    PLoS One; 2022; 17(8):e0272636. PubMed ID: 35947595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent COVID-19 symptoms at least one month after diagnosis: A national survey.
    Tleyjeh IM; Kashour T; Riaz M; Amer SA; AlSwaidan N; Almutairi L; Halwani R; Assiri A
    J Infect Public Health; 2022 May; 15(5):578-585. PubMed ID: 35477145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
    Liang L; Yang B; Jiang N; Fu W; He X; Zhou Y; Ma WL; Wang X
    J Korean Med Sci; 2020 Dec; 35(47):e418. PubMed ID: 33289374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
    Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
    Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Huang C; Huang L; Wang Y; Li X; Ren L; Gu X; Kang L; Guo L; Liu M; Zhou X; Luo J; Huang Z; Tu S; Zhao Y; Chen L; Xu D; Li Y; Li C; Peng L; Li Y; Xie W; Cui D; Shang L; Fan G; Xu J; Wang G; Wang Y; Zhong J; Wang C; Wang J; Zhang D; Cao B
    Lancet; 2023 Jun; 401(10393):e21-e33. PubMed ID: 37321233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.